Lipocine Inc. Files 8-K
Ticker: LPCN · Form: 8-K · Filed: May 22, 2025 · CIK: 1535955
| Field | Detail |
|---|---|
| Company | Lipocine Inc. (LPCN) |
| Form Type | 8-K |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K
Related Tickers: LPCN
TL;DR
LPCN filed an 8-K on 5/22/25 - standard corporate update.
AI Summary
Lipocine Inc. filed an 8-K on May 22, 2025, reporting other events and financial statements. The company, previously known as Marathon Bar Corp until November 30, 2011, is incorporated in Delaware and headquartered in Salt Lake City, Utah.
Why It Matters
This filing indicates routine corporate reporting and potential updates on financial status or significant events for Lipocine Inc.
Risk Assessment
Risk Level: low — This filing appears to be a routine 8-K for corporate reporting, not indicating immediate significant financial or operational changes.
Key Players & Entities
- Lipocine Inc. (company) — Registrant
- Marathon Bar Corp (company) — Former company name
- May 22, 2025 (date) — Date of earliest event reported
- November 30, 2011 (date) — Date of name change from Marathon Bar Corp
- 675 Arapeen Drive, Suite 202 (location) — Principal executive offices address
- Salt Lake City, Utah (location) — City and State of principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Lipocine Inc.?
The filing is for 'Other Events' and 'Financial Statements and Exhibits', indicating routine corporate reporting.
When was the earliest event reported in this filing?
The earliest event reported was on May 22, 2025.
What was Lipocine Inc.'s former company name?
Lipocine Inc.'s former company name was Marathon Bar Corp.
On what date did the company change its name from Marathon Bar Corp?
The date of the name change from Marathon Bar Corp was November 30, 2011.
Where are Lipocine Inc.'s principal executive offices located?
Lipocine Inc.'s principal executive offices are located at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding Lipocine Inc. (LPCN).